Improving outcome for patients after osteoporotic femoral fracture

Not Applicable

Completed

• Conditions: Osteoporosis; Musculoskeletal Diseases

• Registration Number: ISRCTN33363553
• Lead Sponsor: niversity of Edinburgh (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-07-11
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 450

Inclusion Criteria

Patients with acute, traumatic trochanteric or supracondylar femoral fractures who are 55 or older presenting with fragility fractures.

Exclusion Criteria

1. Patients with open fractures, pathological fractures, who have a 'floating knee', associated patellar fracture or simultaneous bilateral fracture.
2. Patients with known metabolic bone disease, rheumatoid arthritis and patients with chronic renal failure.
3. Patients on steroids, strontium, bisphosphonates and parathyroid hormone.
4. Patients with dementia.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The difference between the baseline Johanson Hip Rating Questionnaire (HRQ) score and the HRQ score at six weeks. A target difference of seven to ten points will be considered significant.

Secondary Outcome Measures

Name	Time	Method
Pain and function.